A prospective feasibility study of allogeneic hematopoietic stem cell transplantation using once daily intravenous busulfan and fludarabine as conditioning regime
Not Applicable
- Conditions
- hematological malignancy
- Registration Number
- JPRN-UMIN000029115
- Lead Sponsor
- Osaka International Cancer Institute
- Brief Summary
Because the new treatment schedule was approved by the government, we stopped the study which assessed the feasibility of the same schedule of administration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method